BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7815506)

  • 1. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1995 Feb; 69(2):1280-3. PubMed ID: 7815506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.
    Platt TH; Tcherepanova IY; Schildkraut CL
    J Virol; 1993 Mar; 67(3):1739-45. PubMed ID: 8382320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.
    Chittenden T; Lupton S; Levine AJ
    J Virol; 1989 Jul; 63(7):3016-25. PubMed ID: 2542609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Reisman D; Sugden B
    Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.
    Orlowski R; Miller G
    J Virol; 1991 Feb; 65(2):677-86. PubMed ID: 1846191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.
    Reisman D; Yates J; Sugden B
    Mol Cell Biol; 1985 Aug; 5(8):1822-32. PubMed ID: 3018528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The linking regions of EBNA1 are essential for its support of replication and transcription.
    Mackey D; Sugden B
    Mol Cell Biol; 1999 May; 19(5):3349-59. PubMed ID: 10207059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
    Aiyar A; Aras S; Washington A; Singh G; Luftig RB
    Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
    Gahn TA; Schildkraut CL
    Cell; 1989 Aug; 58(3):527-35. PubMed ID: 2547525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats.
    Dhar V; Schildkraut CL
    Mol Cell Biol; 1991 Dec; 11(12):6268-78. PubMed ID: 1658629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    Wysokenski DA; Yates JL
    J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.
    Koons MD; Van Scoy S; Hearing J
    J Virol; 2001 Nov; 75(22):10582-92. PubMed ID: 11602700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.
    Shirakata M; Imadome KI; Hirai K
    Virology; 1999 Oct; 263(1):42-54. PubMed ID: 10544081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.